MetaCap

Xilio Therapeutics Statistics

NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.56-0.085 (-1.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Xilio Therapeutics by the numbers

Xilio Therapeutics has a market capitalization of $53.4 million based on 7.06M shares outstanding. Its trailing P/E ratio is 11.6. The stock trades 11.6% below its 50-day average and 10.8% below its 200-day average.

Average daily trading volume is 11.54K shares, or about $87,265 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

XLO valuation vs. peer median

XLO compared with the median of 8 peer companies
MetricXLOPeer medianDifference
Market cap$53.40M$53.00M+1%
Avg. volume11.54K114.54K-90%

Peer median across 8 companies: CTOR, XBIT, LFVN, BOLD, AZR, ALDX, CLNN, KZIA.

Valuation

Market cap
$53.40M
Price / sales (latest FY)
1.22

Price and trading

Previous close
7.65
Open
7.60
Day range
7.07 – 7.60
52-week range
6.47 – 10.71
52-week change
-28.29%
Beta
—
Volume
20.10K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
53.40M
Pe
11.63
Forward Pe
-13.03
Eps
0.65
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
10.71
Week52 Low
6.47
Avg Volume
11,543.00
Shares Outstanding
7.06M
Ma50
8.56
Ma200
8.48
Earnings Date
Aug 6, 2025
Pct From52w High
-29.41%
Pct From52w Low
16.88%

Related